Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes

被引:33
作者
Buckingham, Bruce A. [1 ]
Christiansen, Mark P. [2 ]
Forlenza, Gregory P. [3 ]
Wadwa, R. Paul [3 ]
Peyser, Thomas A. [4 ]
Lee, Joon Bok [5 ]
O'Connor, Jason [5 ]
Dassau, Eyal [6 ]
Huyett, Lauren M. [5 ]
Layne, Jennifer E. [5 ]
Ly, Trang T. [5 ]
机构
[1] Stanford Univ, Dept Pediat, Div Pediat Endocrinol, Stanford, CA 94305 USA
[2] Diablo Clin Res, Walnut Creek, CA USA
[3] Univ Colorado, Sch Med, Barbara Davis Ctr Diabet, Aurora, CO USA
[4] ModeAGC LLC, Palo Alto, CA USA
[5] Insulet Corp, Billerica, MA USA
[6] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA
关键词
Artificial pancreas; Automated insulin delivery; Closed-loop; Omnipod; tubeless Insulin pump; Postprandial; AUTOMATED INSULIN DELIVERY; ARTIFICIAL PANCREAS; OUTCOME MEASURES; ADOLESCENTS; IMPACT; MANAGEMENT; FREQUENCY; HBA(1C); SAFETY; SYSTEM;
D O I
10.1089/dia.2018.0138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study assessed the safety and performance of the Omnipod((R)) personalized model predictive control (MPC) algorithm using an investigational device in adults with type 1 diabetes in response to overestimated and missed meal boluses and extended boluses for high-fat meals. Materials and Methods: A supervised 54-h hybrid closed-loop (HCL) study was conducted in a hotel setting after a 7-day outpatient open-loop run-in phase. Adults aged 18-65 years with type 1 diabetes and HbA1c 6.0%-10.0% were eligible. Primary endpoints were percentage time in hypoglycemia <70mg/dL and hyperglycemia 250mg/dL. Glycemic responses for 4h to a 130% overestimated bolus and a missed meal bolus were compared with a 100% bolus for identical meals, respectively. The 12-h postprandial responses to a high-fat meal were compared using either a standard or extended bolus. Results: Twelve subjects participated in the study, with (meanstandard deviation): age 35.4 +/- 14.1 years, diabetes duration 16.5 +/- 9.3 years, HbA1c 7.7 +/- 0.9%, and total daily dose 0.58 +/- 0.19U/kg. Outcomes for the 54-h HCL period were mean glucose 153 +/- 15mg/dL, percentage time <70mg/dL [median (interquartile range)]: 0.0% (0.0-1.2%), 70-180mg/dL: 76.1%+/- 8.0%, and 250mg/dL: 4.5%+/- 3.6%. After both the 100% and 130% boluses, postprandial percentage time <70mg/dL was 0.0% (0.0-0.0%) (P=0.50). After the 100% and missed boluses, postprandial percentage time 250mg/dL was 0.2%+/- 0.6% and 10.3%+/- 16.5%, respectively (P=0.06). Postprandial percentages time 250 mg/dL and <70mg/dL were similar with standard or extended boluses for a high-fat meal. Conclusions: The Omnipod personalized MPC algorithm performed well and was safe during day and night use in response to overestimated, missed, and extended meal boluses in adults with type 1 diabetes.
引用
收藏
页码:585 / 595
页数:11
相关论文
共 28 条
[1]   Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange [J].
Agiostratidou, Gina ;
Anhalt, Henry ;
Ball, Dana ;
Blonde, Lawrence ;
Gourgari, Evgenia ;
Harriman, Karen N. ;
Kowalski, Aaron J. ;
Madden, Paul ;
McAuliffe-Fogarty, Alicia H. ;
McElwee-Malloy, Molly ;
Peters, Anne ;
Raman, Sripriya ;
Reifschneider, Kent ;
Rubin, Karen ;
Weinzimer, Stuart A. .
DIABETES CARE, 2017, 40 (12) :1622-1630
[2]   Introduction [J].
不详 .
DIABETES CARE, 2017, 40 :S1-S130
[3]  
[Anonymous], 2013 AM CONTR C JUN
[4]   The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading [J].
Beck, Roy W. ;
Connor, Crystal G. ;
Mullen, Deborah M. ;
Wesley, David M. ;
Bergenstal, Richard M. .
DIABETES CARE, 2017, 40 (08) :994-999
[5]   Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era [J].
Bell, Kirstine J. ;
Smart, Carmel E. ;
Steil, Garry M. ;
Brand-Miller, Jennie C. ;
King, Bruce ;
Wolpert, Howard A. .
DIABETES CARE, 2015, 38 (06) :1008-1015
[6]   Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes [J].
Bergenstal, Richard M. ;
Garg, Satish ;
Weinzimer, Stuart A. ;
Buckingham, Bruce A. ;
Bode, Bruce W. ;
Tamborlane, William V. ;
Kaufman, Francine R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (13) :1407-1408
[7]   Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm [J].
Buckingham, Bruce A. ;
Forlenza, Gregory P. ;
Pinsker, Jordan E. ;
Christiansen, Mark P. ;
Wadwa, R. Paul ;
Schneider, Jennifer ;
Peyser, Thomas A. ;
Dassau, Eyal ;
Lee, Joon Bok ;
O'Connor, Jason ;
Layne, Jennifer E. ;
Ly, Trang T. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (04) :257-262
[8]   Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery with Type 1 Diabetes [J].
Chase, H. Peter ;
Doyle, Francis J., III ;
Zisser, Howard ;
Renard, Eric ;
Nimri, Revital ;
Cobelli, Claudio ;
Buckingham, Bruce A. ;
Maahs, David M. ;
Anderson, Stacey ;
Magni, Lalo ;
Lum, John ;
Calhoun, Peter ;
Kollman, Craig ;
Beck, Roy W. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) :623-632
[9]   Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus [J].
Chernavvsky, Daniel R. ;
DeBoer, Mark D. ;
Keith-Hynes, Patrick ;
Mize, Benton ;
McElwee, Molly ;
Demartini, Susan ;
Dunsmore, Spencer F. ;
Wakeman, Christian ;
Kovatchev, Boris P. ;
Breton, Marc D. .
PEDIATRIC DIABETES, 2016, 17 (01) :28-35
[10]   REDUCED AWARENESS OF HYPOGLYCEMIA IN ADULTS WITH IDDM - A PROSPECTIVE-STUDY OF HYPOGLYCEMIC FREQUENCY AND ASSOCIATED SYMPTOMS [J].
CLARKE, WL ;
COX, DJ ;
GONDERFREDERICK, LA ;
JULIAN, D ;
SCHLUNDT, D ;
POLONSKY, W .
DIABETES CARE, 1995, 18 (04) :517-522